Thyroid eye disease (TED), also known as Graves’ ophthalmopathy or Graves’ eye disease, is a rare autoimmune disease leading to inflammation and swelling of the tissue around the eyes. As an autoimmune disease, the immune system of an affected individual attacks healthy tissues instead of diseased ones.
Thyroid eye disease usually occurs in people with an overactive thyroid due to Graves’ disease. Graves’ disease is the most common cause of hyperthyroidism in the United States.
Signs and Symptoms of Thyroid Eye Disease
Common symptoms during the active phase of thyroid eye disease (about six months to two years) include pain, discomfort and redness of the eyes, swelling and abnormal positioning of the eyelids, watery eyes, proptosis (bulging eyes), and diplopia (double vision). Once the active phase subsides, what follows is known as the inactive phase, where disease progression has stopped; however, proptosis and diplopia have been known to persist during this phase. Vision loss can occur in extreme cases.
Puffiness around the eyes
Dry, gritty, irritated eyes
Proptosis (bulging eyes)
Diplopia (double vision)
Redness, discomfort, and pain
Sensitivity to light
Further swelling may lead to:
Increased pressure in the eye socket
Trouble moving or closing eyes
Pressure-pain or headaches, made worse by eye movements
Poor vision, colors appear not as bright or even dull.
Blurred or even loss of vision due to corneal damage or compression of the optic nerve.
Causes of Thyroid Eye Disease
Eye symptoms can develop within six months of Graves’ disease diagnosis, although Graves’ disease does not directly cause TED. Both thyroid eye disease and Graves’ disease result in a similar immune response of an attack on healthy tissue but one does not directly result in the other. Risk Factors
Approximately one million Americans are diagnosed with thyroid eye disease each year. Thyroid eye disease is also known to occur in affected individuals with normal or low levels of thyroid hormones (hypothyroid). However, it is most common among individuals with overactive thyroids causing an increase in thyroid hormone production (hyperthyroidism). Some Risk Factors include:
Thyroid Eye Disease Treatment and Management
Contact your primary care physician and/or ophthalmologist if you think you have thyroid eye disease. Thyroid eye disease can be treated by your ophthalmologist, underlying thyroid issues are managed by your primary care physician, and hormonal treatment can be managed by an endocrinologist.
Treatment includes medication aimed to reduce hormones produced by the thyroid gland, in order to return your thyroid to normal function. Radioactive iodine is used to eliminate hormone-producing cells and various surgeries including eyelid surgery, eye muscle surgery, and orbital decompression surgery.
More treatments include quitting smoking (if you are a smoker), steroids to reduce swelling, taping over your eyelids to protect your corneas while sleeping, and elevating your head to reduce swelling.
A recent breakthrough drug reviewed in a clinical trial by the University of Michigan Kellogg Eye Centers offers additional help and hope for those with severe to moderate thyroid eye disease. Patients treated with tetrotumumab experienced a reduced severity of symptoms. Foundations and Societies
Get Support for Thyroid Eye Disease
Newly diagnosed with thyroid eye disease or know someone that was? You can talk with other Healthread users who might have or have had TED about your symptoms and management.
Sources